The challenges of tuberculosis control in protracted conflict: The case of Syria

被引:20
作者
Abbara, Aula [1 ]
Almalla, Mohamed [2 ]
AlMasri, Ibrahim [3 ]
AlKabbani, Hussam [4 ]
Karah, Nabil [5 ,6 ]
El-Amin, Wael [7 ]
Rajan, Latha [8 ]
Rahhal, Ibrahim [9 ]
Alabbas, Mohammad [9 ]
Sahloul, Zaher [10 ]
Tarakji, Ahmad [11 ]
Sparrow, Annie [12 ]
机构
[1] Imperial Coll, London, England
[2] Amer Univ Beirut, Beirut, Lebanon
[3] Univ Calgary, OBrien Inst Publ Hlth, Cumming Sch Med, Calgary, AB, Canada
[4] Al Ameen Humanitarian Support, Dept Hlth & Nutr, Gaziantep, Turkey
[5] Lab Mol Infect Med Sweden, Dept Mol Biol, Umea, Sweden
[6] Umea Ctr Microbial Res, Umea, Sweden
[7] Kings Coll Hosp London, Dubai, U Arab Emirates
[8] Tulane Univ, Sch Publ Hlth & Trop Med, New Orleans, LA USA
[9] Hand Hand Aid & Dev, Gaziantep, Turkey
[10] Univ Illinois, Dept Pulmonol & Crit Care, Chicago, IL USA
[11] Syrian Amer Med Soc, Washington, DC USA
[12] Icahn Sch Med Mt Sinai, Dept Populat Hlth Sci & Policy, New York, NY 10029 USA
关键词
Tuberculosis; Syria; Conflict; Refugees; Drug resistance; Prisoners; Besiegement; CARE;
D O I
10.1016/j.ijid.2019.10.015
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objectives: Syria's protracted conflict has resulted in ideal conditions for the transmission of tuberculosis (TB) and the cultivation of drug-resistant strains. This paper compares TB control in Syria before and after the conflict using available data, examines the barriers posed by protracted conflict and those specific to Syria, and discusses what measures can be taken to address the control of TB in Syria. Results: Forced mass displacement and systematic violations of humanitarian law have resulted in overcrowding and the destruction of key infrastructure, leading to an increased risk of both drug-sensitive and resistant TB, while restricting the ability to diagnose, trace contacts, treat, and follow-up. Pre-conflict, TB in Syria was officially reported at 22 per 100 000 population; the official figure for 2017 of 19 per 100 000 is likely a vast underestimate given the challenges and barriers to case detection. Limited diagnostics also affect the diagnosis of multidrug- and rifampicin-resistant TB, reported as comprising 8.8% of new diagnoses in 2017. Conclusions: The control of TB in Syria requires a multipronged, tailored, and pragmatic approach to improve timely diagnosis, increase detection, stop transmission, and mitigate the risk of drug resistance. Solutions must also consider vulnerable populations such as imprisoned and besieged communities where the risk of drug resistance is particularly high, and must recognize the limitations of national programming. Strengthening capacity to control TB in Syria with particular attention to these factors will positively impact other parallel conditions; this is key as attention turns to post-conflict reconstruction. (C) 2019 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
引用
收藏
页码:53 / 59
页数:7
相关论文
共 39 条
[1]  
Abbara A., 2016, World Health & Population, V16, P87, DOI [DOI 10.12927/WHP.2015.24318, 10.12927/whp.2015.24318]
[2]   Antimicrobial resistance in the context of the Syrian conflict: Drivers before and after the onset of conflict and key recommendations [J].
Abbara, Aula ;
Rawson, Timothy M. ;
Karah, Nabil ;
El-Amin, Wael ;
Hatcher, James ;
Tajaldin, Bachir ;
Dar, Osman ;
Dewachi, Omar ;
Abu Sitta, Ghassan ;
Uhlin, Bernt Eric ;
Sparrow, Annie .
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2018, 73 :1-6
[3]   Populations under siege and in prison require investment from Syria's national tuberculosis programme [J].
Abbara, Aula ;
AlKabbani, Hussam ;
Al-Masri, Ibrahim ;
Sahloul, Zaher ;
Sparrow, Annie .
LANCET RESPIRATORY MEDICINE, 2018, 6 (07) :E34-E34
[4]  
[Anonymous], ESCMID ABSTR
[5]  
[Anonymous], SYRIAN AR REP WHO UN
[6]  
[Anonymous], 10 Q REPORT 1
[7]  
[Anonymous], HLTH CLUST B OCT 201
[8]  
[Anonymous], J GLOB HLTH
[9]  
[Anonymous], 2018, SIT SYR REG REF RESP
[10]  
[Anonymous], 2011, Global Tuberculosis Control 2011